Crofelemer, a novel plant-based anti-secretory prescription drug, has been granted Orphan Drug Designation by the FDA and the European Medicines Agency (EMA) for both short bowel syndrome (SBS) and ...

VANCOUVER, WASHINGTON / ACCESS Newswire / April 17, 2025 / Sinceri Senior Living today announced a series of promotions of key executives to further align its team with the company's operational ...

TURKU, FI / ACCESS Newswire / April 17, 2025 / Faron Pharmaceuticals Ltd. (AIM:FARN)(First North:FARON)(HEL:FARON)(LSE:FARN), a clinical-stage biopharmaceutical company focused on developing novel ...

In the fast-paced pharmaceutical industry, sales teams face increasing pressure to meet sales targets, engage healthcare ...